Basile Tessier-Cloutier
Overview
Explore the profile of Basile Tessier-Cloutier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shin C, Gokbayrak B, Tao V, Almadani N, S Li E, Ho R, et al.
Histopathology
. 2025 Jan;
PMID: 39811899
Aims: Classification and risk stratification of endometrial carcinoma (EC) has transitioned from histopathological features to molecular classification, e.g. the ProMisE classifier, identifying four prognostic subtypes: POLE mutant (POLEmut) with almost...
2.
Stolnicu S, Allison D, Tessier-Cloutier B, Momeni-Boroujeni A, Hoang L, Ieni A, et al.
Pathology
. 2024 Oct;
57(1):17-26.
PMID: 39477763
The aim of this study was to determine whether the presence and extent of lymphovascular invasion (LVI) is prognostic in surgical stage I cervical squamous cell carcinoma (SCC). All available...
3.
El Mokbel N, Goyeneche A, Prakash R, Forgie B, Abdalbari F, Zeng X, et al.
Biochem Biophys Rep
. 2024 Oct;
40:101838.
PMID: 39469046
High-grade serous cancer is the most common type of ovarian cancer and is usually diagnosed at advanced stages with high mortality due to recurrence and eventual resistance to standard platinum...
4.
Dhillon G, Llaurado-Fernandez M, Tessier-Cloutier B, Sy K, Bassiouny D, Han G, et al.
Front Oncol
. 2024 Sep;
14:1408196.
PMID: 39220645
Objectives: Ovarian carcinosarcoma (OCS) is a rare and lethal type of ovarian cancer. Despite its incredibly poor prognosis, it has received little research attention. In this study, we aim to...
5.
Ji J, Hoang L, Cochrane D, Lum A, Senz J, Farnell D, et al.
J Pathol
. 2024 Aug;
264(2):160-173.
PMID: 39096103
Clear cell ovarian carcinoma (CCOC) is an aggressive malignancy affecting younger women. Despite ovarian cancer subtypes having diverse molecular and clinical characteristics, the mainstay of treatment for advanced stage disease...
6.
Della Rocca C, Tessier-Cloutier B, Zakhari A
J Obstet Gynaecol Can
. 2024 Jul;
46(8):102605.
PMID: 38950879
No abstract available.
7.
Chiang S, Tessier-Cloutier B, Klein E, Ardon O, Mueller J, Leitao Jr M, et al.
Int J Gynecol Cancer
. 2024 Feb;
34(5):681-688.
PMID: 38388180
Background: Many sentinel lymph node (SLN) ultrastaging protocols for endometrial cancer exist, but there is no consensus method. Objective: This study aims to develop guidelines for size criteria in SLN...
8.
Huber R, Lee J, Borretta L, Tessier-Cloutier B, Lum A, Yip S, et al.
Hum Pathol
. 2024 Jan;
144:34-39.
PMID: 38224873
The majority of melanocytic proliferations can be readily categorized as benign or malignant based on histologic assessment under the microscope by a trained dermatopathologist. However, a subset of lesions, termed...
9.
Stolnicu S, Praiss A, Allison D, Tessier-Cloutier B, Flynn J, Iasonos A, et al.
Int J Gynecol Pathol
. 2023 Dec;
43(3):203-214.
PMID: 38085957
We compared grading systems and examined associations with tumor stroma and survival in patients with cervical squamous cell carcinoma. Available tumor slides were collected from 10 international institutions. Broders tumor...
10.
Tessier-Cloutier B, Kommoss F, Kolin D, Nemejcova K, Smith D, Pors J, et al.
Mod Pathol
. 2023 Nov;
37(1):100374.
PMID: 37925057
Dedifferentiated and undifferentiated ovarian carcinomas (DDOC/UDOC) are rare neoplasms defined by the presence of an undifferentiated carcinoma. In this study, we detailed the clinical, pathological, immunohistochemical, and molecular features of...